A citation-based method for searching scientific literature

N Gupta, I M Oppenheim, E F Kauvar, N Tayebi, E Sidransky. Blood Cells Mol Dis 2011
Times Cited: 52







List of co-cited articles
616 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
E Sidransky, M A Nalls, J O Aasly, J Aharon-Peretz, G Annesi, E R Barbosa, A Bar-Shira, D Berg, J Bras, A Brice,[...]. N Engl J Med 2009
38

Gaucher disease: complexity in a "simple" disorder.
Ellen Sidransky. Mol Genet Metab 2004
264
30

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
Kathleen S Hruska, Mary E LaMarca, C Ronald Scott, Ellen Sidransky. Hum Mutat 2008
402
28

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Joseph R Mazzulli, You-Hai Xu, Ying Sun, Adam L Knight, Pamela J McLean, Guy A Caldwell, Ellen Sidransky, Gregory A Grabowski, Dimitri Krainc. Cell 2011
866
26

Type 2 Gaucher disease: 15 new cases and review of the literature.
Cyril Mignot, Diana Doummar, Irène Maire, Thierry Billette De Villemeur. Brain Dev 2006
81
25

The clinical management of Type 2 Gaucher disease.
Karin Weiss, Ashley Gonzalez, Grisel Lopez, Leah Pedoeim, Catherine Groden, Ellen Sidransky. Mol Genet Metab 2015
52
23

Neuropathology provides clues to the pathophysiology of Gaucher disease.
Kondi Wong, Ellen Sidransky, Ajay Verma, Tonghui Mixon, Glenn D Sandberg, Laura K Wakefield, Alan Morrison, Alicia Lwin, Carlos Colegial, John M Allman,[...]. Mol Genet Metab 2004
318
21

Murine models of acute neuronopathic Gaucher disease.
Ida Berglin Enquist, Christophe Lo Bianco, Andreas Ooka, Eva Nilsson, Jan-Eric Månsson, Mats Ehinger, Johan Richter, Roscoe O Brady, Deniz Kirik, Stefan Karlsson. Proc Natl Acad Sci U S A 2007
121
21

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.
Ozlem Goker-Alpan, Raphael Schiffmann, Joseph K Park, Barbara K Stubblefield, Nahid Tayebi, Ellen Sidransky. J Pediatr 2003
92
21

Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
Gustavo H B Maegawa, Michael B Tropak, Justin D Buttner, Brigitte A Rigat, Maria Fuller, Deepangi Pandit, Liangiie Tang, Gregory J Kornhaber, Yoshitomo Hamuro, Joe T R Clarke,[...]. J Biol Chem 2009
198
21

Management of neuronopathic Gaucher disease: revised recommendations.
A Vellodi, A Tylki-Szymanska, E H Davies, E Kolodny, B Bembi, T Collin-Histed, E Mengel, A Erikson, R Schiffmann. J Inherit Metab Dis 2009
62
19

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.
Valerie Cullen, S Pablo Sardi, Juliana Ng, You-Hai Xu, Ying Sun, Julianna J Tomlinson, Piotr Kolodziej, Ilana Kahn, Paul Saftig, John Woulfe,[...]. Ann Neurol 2011
231
19


Perinatal-lethal Gaucher disease.
C Mignot, A Gelot, B Bessières, F Daffos, M Voyer, F Menez, C Fallet Bianco, S Odent, D Le Duff, P Loget,[...]. Am J Med Genet A 2003
67
19

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.
S Pablo Sardi, Jennifer Clarke, Cathrine Kinnecom, Thomas J Tamsett, Lingyun Li, Lisa M Stanek, Marco A Passini, Gregory A Grabowski, Michael G Schlossmacher, Richard L Sidman,[...]. Proc Natl Acad Sci U S A 2011
216
17

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
Paige Kaplan, Hans C Andersson, Katherine A Kacena, John D Yee. Arch Pediatr Adolesc Med 2006
124
17

Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse.
Ying Sun, Huimin Ran, Benjamin Liou, Brian Quinn, Matt Zamzow, Wujuan Zhang, Jacek Bielawski, Kazuyuki Kitatani, Kenneth D R Setchell, Yusuf A Hannun,[...]. PLoS One 2011
43
18

Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease.
E Sidransky, M Fartasch, R E Lee, L A Metlay, S Abella, A Zimran, W Gao, P M Elias, E I Ginns, W M Holleran. Pediatr Res 1996
65
15

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype.
A Abrahamov, D Elstein, V Gross-Tsur, B Farber, Y Glaser, I Hadas-Halpern, S Ronen, M Tafakjdi, M Horowitz, A Zimran. Lancet 1995
153
15

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
V Koprivica, D L Stone, J K Park, M Callahan, A Frisch, I J Cohen, N Tayebi, E Sidransky. Am J Hum Genet 2000
219
15

Twin pairs showing discordance of phenotype in adult Gaucher's disease.
R H Lachmann, I R Grant, D Halsall, T M Cox. QJM 2004
109
15

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
J Charrow, H C Andersson, P Kaplan, E H Kolodny, P Mistry, G Pastores, B E Rosenbloom, C R Scott, R S Wappner, N J Weinreb,[...]. Arch Intern Med 2000
332
15

Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.
Eduard Orvisky, Joseph K Park, Mary E LaMarca, Edward I Ginns, Brian M Martin, Nahid Tayebi, Ellen Sidransky. Mol Genet Metab 2002
128
15

Divergent phenotypes in Gaucher disease implicate the role of modifiers.
O Goker-Alpan, K S Hruska, E Orvisky, P S Kishnani, B K Stubblefield, R Schiffmann, E Sidransky. J Med Genet 2005
83
15

Parkinsonism among Gaucher disease carriers.
O Goker-Alpan, R Schiffmann, M E LaMarca, R L Nussbaum, A McInerney-Leo, E Sidransky. J Med Genet 2004
243
15

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Jérôme Stirnemann, Nadia Belmatoug, Fabrice Camou, Christine Serratrice, Roseline Froissart, Catherine Caillaud, Thierry Levade, Leonardo Astudillo, Jacques Serratrice, Anaïs Brassier,[...]. Int J Mol Sci 2017
275
15

Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease.
You-Hai Xu, Brian Quinn, David Witte, Gregory A Grabowski. Am J Pathol 2003
124
13

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
Richie Khanna, Elfrida R Benjamin, Lee Pellegrino, Adriane Schilling, Brigitte A Rigat, Rebecca Soska, Hadis Nafar, Brian E Ranes, Jessie Feng, Yi Lun,[...]. FEBS J 2010
108
13

Gaucher disease: enzyme therapy in the acute neuronopathic variant.
C A Prows, N Sanchez, C Daugherty, G A Grabowski. Am J Med Genet 1997
66
13

Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
V L Tybulewicz, M L Tremblay, M E LaMarca, R Willemsen, B K Stubblefield, S Winfield, B Zablocka, E Sidransky, B M Martin, S P Huang. Nature 1992
244
13

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.
W M Holleran, E I Ginns, G K Menon, J U Grundmann, M Fartasch, C E McKinney, P M Elias, E Sidransky. J Clin Invest 1994
218
13

Increased incidence of cancer in adult Gaucher disease in Western Europe.
M de Fost, S Vom Dahl, G J Weverling, N Brill, S Brett, D Häussinger, C E M Hollak. Blood Cells Mol Dis 2006
128
13


Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation.
A Chabás, B Cormand, D Grinberg, J M Burguera, S Balcells, J L Merino, I Mate, J A Sobrino, R Gonzàlez-Duarte, L Vilageliu. J Med Genet 1995
91
13

A monozygotic twin pair with highly discordant Gaucher phenotypes.
M Biegstraaten, I N van Schaik, J M F G Aerts, M Langeveld, M M A M Mannens, L J Bour, E Sidransky, N Tayebi, E Fitzgibbon, C E M Hollak. Blood Cells Mol Dis 2011
48
14

LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
David Reczek, Michael Schwake, Jenny Schröder, Heather Hughes, Judith Blanz, Xiaoying Jin, William Brondyk, Scott Van Patten, Tim Edmunds, Paul Saftig. Cell 2007
340
13

Therapeutic goals in the treatment of Gaucher disease.
Gregory M Pastores, Neal J Weinreb, Hans Aerts, Generoso Andria, Timothy M Cox, Manuel Giralt, Gregory A Grabowski, Pramod K Mistry, Anna Tylki-Szymańska. Semin Hematol 2004
274
13

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
N W Barton, R O Brady, J M Dambrosia, A M Di Bisceglie, S H Doppelt, S C Hill, H J Mankin, G J Murray, R I Parker, C E Argoff. N Engl J Med 1991
992
13

Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implications.
Aegean Chan, Walter M Holleran, Tajh Ferguson, Debra Crumrine, Ozlem Goker-Alpan, Raphael Schiffmann, Nahid Tayebi, Edward I Ginns, Peter M Elias, Ellen Sidransky. Mol Genet Metab 2011
19
36

The saccadic and neurological deficits in type 3 Gaucher disease.
William Benko, Markus Ries, Edythe A Wiggs, Roscoe O Brady, Raphael Schiffmann, Edmond J Fitzgibbon. PLoS One 2011
41
17

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
Michael A Nalls, Raquel Duran, Grisel Lopez, Marzena Kurzawa-Akanbi, Ian G McKeith, Patrick F Chinnery, Christopher M Morris, Jessie Theuns, David Crosiers, Patrick Cras,[...]. JAMA Neurol 2013
271
13


Randomized, controlled trial of miglustat in Gaucher's disease type 3.
Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, Catherine DeVile, Elin H Davies, Larry Abel, Ivo N van Schaik, William Benko, Margaret Timmons, Markus Ries,[...]. Ann Neurol 2008
145
13

No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.
Tamar Farfel-Becker, Einat Vitner, Hani Dekel, Noa Leshem, Ida Berglin Enquist, Stefan Karlsson, Anthony H Futerman. Hum Mol Genet 2009
42
14

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
Neal J Weinreb, Joel Charrow, Hans C Andersson, Paige Kaplan, Edwin H Kolodny, Pramod Mistry, Gregory Pastores, Barry E Rosenbloom, C Ronald Scott, Rebecca S Wappner,[...]. Am J Med 2002
378
11

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
Ying Sun, Benjamin Liou, Huimin Ran, Matthew R Skelton, Michael T Williams, Charles V Vorhees, Kazuyuki Kitatani, Yusuf A Hannun, David P Witte, You-Hai Xu,[...]. Hum Mol Genet 2010
93
11

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Anu R Sawkar, Wei-Chieh Cheng, Ernest Beutler, Chi-Huey Wong, William E Balch, Jeffery W Kelly. Proc Natl Acad Sci U S A 2002
386
11

Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
Tamar Farfel-Becker, Einat B Vitner, Sarah N R Pressey, Raya Eilam, Jonathan D Cooper, Anthony H Futerman. Hum Mol Genet 2011
70
11

Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies.
N G Conradi, P Sourander, O Nilsson, L Svennerholm, A Erikson. Acta Neuropathol 1984
89
11

Gaucher disease and cancer incidence: a study from the Gaucher Registry.
Barry E Rosenbloom, Neal J Weinreb, Ari Zimran, Katherine A Kacena, Joel Charrow, Elizabeth Ward. Blood 2005
156
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.